BPC 157 can be taken orally or subcutaneously, and for most people there is no difference in efficacy.Yes, some people will notice one works better than the other. Yes, some people will claim that Beginner's Guide to Peptide Therapy [2026] BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Dosis para mezcla de BPC157 y TB500 BPC 157, TB 500 20mg (Blend), Powder, Packaging Type: Bottle at 19000 box in Nagpur BPC 157 in Australia: Benefits, side effects, risks and legality